Shares of OPKO Health (NASDAQ: OPK) surged 10.8% on Wednesday after the U.S. Centers for Disease Control and Prevention (CDC) said it could file for approval of a test for the COVID-19 coronavirus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,